Robert E. Landry - Dec 8, 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Finance CFO
Signature
/s/**Robert E. Landry
Stock symbol
REGN
Transactions as of
Dec 8, 2023
Transactions value $
-$3,573,573
Form type
4
Date filed
12/12/2023, 04:01 PM
Previous filing
Aug 25, 2023
Next filing
Dec 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Tax liability -$855K -1.01K -3.2% $843.79 30.7K Dec 8, 2023 Direct
transaction REGN Common Stock Tax liability -$565K -669 -2.18% $844.09 30K Dec 11, 2023 Direct
transaction REGN Common Stock Tax liability -$2.15M -2.55K -8.5% $844.09 27.5K Dec 11, 2023 Direct
holding REGN Common Stock 270 Dec 8, 2023 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.